A5054827279- Dementia and Cognitive Impairment Research
- Alzheimer's disease research and treatments
- Healthcare Systems and Practices
- Acute Ischemic Stroke Management
- Advanced Neuroimaging Techniques and Applications
- Moyamoya disease diagnosis and treatment
- MRI in cancer diagnosis
- Mitochondrial Function and Pathology
- Neurological Complications and Syndromes
- Mental Health and Psychiatry
- Health Systems, Economic Evaluations, Quality of Life
- Cerebrospinal fluid and hydrocephalus
- Neurological and metabolic disorders
- Advanced MRI Techniques and Applications
- Anesthesia and Sedative Agents
- Radiomics and Machine Learning in Medical Imaging
- Memory Processes and Influences
- Neurosurgical Procedures and Complications
- Cerebral Venous Sinus Thrombosis
- Health, Environment, Cognitive Aging
- ATP Synthase and ATPases Research
- Vasculitis and related conditions
- Glaucoma and retinal disorders
- Multisensory perception and integration
- Transportation and Mobility Innovations
CHU Dinant Godinne UCL Namur
2000-2021
UCLouvain
2001-2021
Many people fear that the disclosure of diagnosis Alzheimer disease (AD) to patients will prompt depressive symptoms or catastrophic reactions. We aimed prospectively evaluate modification anxiety and 3 months after AD.A total 100 consecutive newly diagnosed with AD (mild moderate stage) their caregivers were included. The evolution depression was assessed Zung Self-Rating Depression Scale (Zung SDS) item Neuropsychiatric Inventory (NPI-d) (NPI-a). After months, asked opinions on global...
<b><i>Background/Aims:</i></b> Dementia is one of the main reasons for institutionalization among elderly. Few studies have explored factors associated with caregivers’ (CG) desire to institutionalize (DTI) a person dementia (PWD). The objective this study identify modifiable and non-modifiable psychosocial sociodemographic caregiver’s DTI. <b><i>Methods:</i></b> Cross-sectional data 355 informal CG community-dwelling PWD were analyzed. Several...
Background: The five-word test (FWT) uses semantic clues to optimize the encoding and retrieval of 5 items. Our objective was assess validity FWT as a measure episodic memory when compared with Free Cued Selective Reminding Test (FCSRT), its ability distinguish participants any dementia especially Alzheimer disease (AD) from those only subjective complaints. Methods: Two hundred Mini-Mental State Examination (MMSE) >15 were prospectively evaluated. sum immediate delayed free recalls is...
Background: Magnetic resonance imaging (MRI) acquisition/processing techniques assess brain volumes to explore neurodegeneration in Alzheimer's disease (AD).Objective: We examined the clinical utility of MSmetrix and investigated if automated MRI could discriminate between groups covering AD continuum be used as a predictor for progression.Methods: The Belgian Dementia Council initiated retrospective, multi-center study analyzed whole (WB), grey matter (GM), white (WM), cerebrospinal fluid...
Background: Palliative care and Advance Care Planning (ACP) are increasingly recommended for an optimal management of late-stage dementia. In Belgium, euthanasia has been decriminalized in 2002 patients who “mentally competent” (interpreted as non-demented). It suggested that advance directives (ADE) should be made possible dementia patients. Objective: This study presents the results internet survey among Belgian specialists. Methods: 2013, Dementia Council (BeDeCo) organized a debate on...
Abstract Objective Mitochondrial dysfunction plays a key role in the pathophysiology of neurodegenerative disorders such as ataxia and Parkinson's disease. We describe an extended Belgian pedigree where seven individuals presented with adult‐onset cerebellar ataxia, axonal peripheral ataxic neuropathy, tremor, variable combination parkinsonism, seizures, cognitive decline, ophthalmoplegia. sought to identify underlying molecular etiology characterize mitochondrial this neurological syndrome....
Magnetic resonance imaging (MRI) has become important in the diagnostic work-up of neurodegenerative diseases. icobrain dm, a CE-labeled and FDA-cleared automated brain volumetry software, shown potential differentiating cognitively healthy controls (HC) from Alzheimer's disease (AD) dementia (ADD) patients selected research cohorts.This study examines value dm for AD routine clinical practice, including comparison to widely used FreeSurfer investigates if combined volumes contribute...